CERo Therapeutics Holdings, Inc. (NASDAQ:CEROW) Sees Significant Decline in Short Interest

CERo Therapeutics Holdings, Inc. (NASDAQ:CEROW) saw a significant drop in short interest in the month of March. As of March 15th, there was short interest totalling 16,900 shares, a drop of 54.0% from the February 28th total of 36,700 shares. Based on an average daily volume of 107,500 shares, the short-interest ratio is presently 0.2 days.

CERo Therapeutics Price Performance

CERo Therapeutics stock opened at $0.01 on Friday. The company’s fifty day moving average price is $0.01 and its 200 day moving average price is $0.01. CERo Therapeutics has a 1 year low of $0.00 and a 1 year high of $0.13.

CERo Therapeutics Company Profile

CERo Therapeutics Holdings, Inc, an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies. The company was incorporated in 2021 and is based in South San Francisco, California.